Arcturus Therapeutics Holdings Inc.’s ARCT share price has surged by 11.71%, which has investors questioning if this is right ...

Arcturus Therapeutics Holdings Inc. (the "Company", "Arcturus", Nasdaq: ARCT), a commercial messenger RNA medicines company ...

Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT), a commercial-stage biotechnology company with a market capitalization of $428 million specializing in mRNA therapeutics and vaccines, stands at a ...

While the virus hasn’t made a sustained leap into humans, vaccines and treatments are being developed ahead of an outbreak.

SARS-CoV-2 is a positive-sense single-stranded RNA virus. It is contagious in humans and is the cause of the coronavirus disease 2019 (COVID-19). Non-active site mutations such as L50F are crucial ...

Meiji Seika Pharma Co., Ltd. (Headquarters: Tokyo, Japan, President and Representative Director: Daikichiro Kobayashi) ...

UNIONDALE, NY / ACCESS Newswire / January 30, 2025 / Marquis Who's Who celebrates Antony Jackson Arumairaj, MD, for excellence in medicine. Dr. Arumairaj was recently featured on a 22-story screen in ...

Exceptional Growth Potential "The demand for lift platforms is expected to remain strong in the coming years, driven by sustained growth in the company's end markets, following the slowdown caused by ...

Arcturus Therapeutics Holdings Inc. (the "Company", "Arcturus", Nasdaq: ARCT), a commercial messenger RNA medicines company ...

Fintel reports that on January 28, 2025, BTIG initiated coverage of Arcturus Therapeutics Holdings (NasdaqGM:ARCT) with a Buy ...

Arcturus Therapeutics Holdings Inc. stock is down 46% since Sept. 2023 coverage; mRNA sector faces headwinds with public ...

A 'zombie star' could be resurrected on Halloween night, experts say. T Coronae Borealis, also known as the 'Blaze Star,' is expected to explode, which will illuminate a dead binary star system.